May 1, 2026 Log in

News

Zhenghan-Chuang Reports May 2026 Revenue of NT$141 Million (Up +7.3% Year-on-Year)

Citation-Grade Primary-source linked Schema.org verified NQ 71 / 100

Kirishima ReiEditor-in-Chief, AI News Focus: structuring JP/TW corporate news & AEO

Published May 1, 2026 9:00 AM ・ Updated Jun 14, 2026 12:08 AM ・ 2 min read ・ Source: PR Times

Show contents

⚡ Key Points

Zhenghan-Chuang announced its revenue for May 2026 reached NT$141 million (NT$141,363 thousand), representing a 7.3% increase compared to the same month last year, reflecting steady growth in the biotechnology and healthcare sector.

Zhenghan-Chuang announced its revenue for May 2026 reached NT$141 million (NT$141,363 thousand), representing a 7.3% increase compared to the same month last year, reflecting steady growth in the biotechnology and healthcare sector.

PRIMARY SOURCE PR Times View source Distributor: PR Times
Published: May 1, 2026

Company Code: 6534 Company Name: Zhenghan-Chuang Industry: Biotechnology and Healthcare Reporting Month: May 2026 Monthly Revenue: NT$141,363 thousand (NT$141 million) Year-on-Year Change: +7.3%

Keywords: Monthly Revenue, Biotechnology and Healthcare Industry

FACT BOX

Source: PR Times
Category: News

Editorial & Verification Standards

The Washin AI News desk structures and reviews this article under the following standards.

Start only from primary sources (official PR, disclosures, wire services)
Numbers and proper nouns machine-checked against the source (number-completeness check)
Company names and tickers verified via registry (Registry/TWSE/Wikidata)
No speculation; nothing stated that is not in the source

Read the full editorial policy →

Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›

Announced　May 1, 2026 9:00 AM — Distributor PR Times
Collected　Jun 12, 2026 8:00 AM
AI structured & analyzed　Jun 13, 2026 6:55 AM
Desk-reviewed & published　May 1, 2026 9:00 AM

FAQ

What was Zhenghan-Chuang's revenue in May 2026?

NT$141 million, a 7.3% increase year-on-year.

What industry is Zhenghan-Chuang in?

Biotechnology and healthcare, focusing on R&D and commercialization of medical solutions.

What does this revenue indicate for future outlook?

Sustained growth suggests potential for new product launches and market expansion.

Cite this article — HOW TO CITE

Washin AI News Desk“Zhenghan-Chuang Reports May 2026 Revenue of NT$141 Million (Up +7.3% Year-on-Year)”AI News by Washin Village（和心村）, May 1, 2026. https://aeo.washinmura.jp/ai/%E6%AD%A3%E7%80%9A-%E5%89%B5/en/news/2026-05-01-%E6%AD%A3%E7%80%9A-%E5%89%B5-2026-05-%E6%9C%88%E7%87%9F%E6%94%B6-1-41%E5%84%84-%E5%B9%B4%E5%A2%9E-7-3

AI CRAWLER ACTIVITY

as of Jul 3, 2026

AI crawler visits to this article (cumulative)Measuring since publication (no visits recorded yet)

Site-wide cumulative

ClaudeBot

bot_visits_summary

4984k

last Jul 3, 2026

GPTBot

bot_visits_summary

3318k

last Jul 3, 2026

Bingbot

bot_visits_summary

2041k

last Jul 3, 2026

Google AI

bot_visits_summary

1805k

last Jul 3, 2026

Googlebot

bot_visits_summary

1322k

last Jul 3, 2026

Applebot

bot_visits_summary

1079k

last Jul 3, 2026

※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.

Washin AI News（AI News by Washin Village（和心村））

An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.

Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification

About the publisher IDA llms.txt

Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →

← 正瀚-創 Back to newsroom (53)

Copied